Dosimetric evaluation of magnetic resonance imaging-guided adaptive radiation therapy in pancreatic cancer by extent of re-contouring of organs-at-risk.

IF 1.8 Q3 ONCOLOGY
Jun Yeong Song, Eui Kyu Chie, Seong-Hee Kang, Yeon-Jun Jeon, Yoon-Ah Ko, Dong-Yun Kim, Hyun-Cheol Kang
{"title":"Dosimetric evaluation of magnetic resonance imaging-guided adaptive radiation therapy in pancreatic cancer by extent of re-contouring of organs-at-risk.","authors":"Jun Yeong Song,&nbsp;Eui Kyu Chie,&nbsp;Seong-Hee Kang,&nbsp;Yeon-Jun Jeon,&nbsp;Yoon-Ah Ko,&nbsp;Dong-Yun Kim,&nbsp;Hyun-Cheol Kang","doi":"10.3857/roj.2022.00332","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The safety of online contouring and planning for adaptive radiotherapy is unknown. This study aimed to evaluate the dosimetric difference of the organ-at-risk (OAR) according to the extent of contouring in stereotactic magnetic resonance image-guided adaptive RT (SMART) for pancreatic cancer.</p><p><strong>Materials and methods: </strong>We reviewed the treatment plan data used for SMART in patients with pancreatic cancer. For the online contouring and planning, OARs within 2 cm from the planning target volume (PTV) in the craniocaudal direction were re-controlled daily at the attending physician's discretion. The entire OARs were re-contoured retrospectively for data analysis. We termed the two contouring methods the Rough OAR and the Full OAR, respectively. The proportion of dose constraint violation and other dosimetric parameters was analyzed.</p><p><strong>Results: </strong>Nineteen patients with 94 fractions of SMART were included in the analysis. The dose constraint was violated in 10.6% and 43.6% of the fractions in Rough OAR and Full OAR methods, respectively (p = 0.075). Patients with a large tumor, a short distance from gross tumor volume (GTV) to OAR, and a tumor in the body or tail were associated with more occult dose constraint violations-large tumor (p = 0.027), short distance from GTV to OAR (p = 0.061), tumor in body or tail (p = 0.054). No dose constraint violation occurred outside 2 cm from the PTV.</p><p><strong>Conclusion: </strong>More occult dose constraint violations can be found by the Full OAR method in patients with pancreatic cancer with some clinical factors in the online re-planning for SMART. Re-contouring all the OARs would be helpful to detect occult dose constraint violations in SMART planning. Since the dosimetric profile of SMART cannot be represented by a single fraction, patient selection for the Full OAR method should be weighted between the clinical usefulness and the time and workforce required.</p>","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/d0/roj-2022-00332.PMC9830039.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiation Oncology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3857/roj.2022.00332","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Purpose: The safety of online contouring and planning for adaptive radiotherapy is unknown. This study aimed to evaluate the dosimetric difference of the organ-at-risk (OAR) according to the extent of contouring in stereotactic magnetic resonance image-guided adaptive RT (SMART) for pancreatic cancer.

Materials and methods: We reviewed the treatment plan data used for SMART in patients with pancreatic cancer. For the online contouring and planning, OARs within 2 cm from the planning target volume (PTV) in the craniocaudal direction were re-controlled daily at the attending physician's discretion. The entire OARs were re-contoured retrospectively for data analysis. We termed the two contouring methods the Rough OAR and the Full OAR, respectively. The proportion of dose constraint violation and other dosimetric parameters was analyzed.

Results: Nineteen patients with 94 fractions of SMART were included in the analysis. The dose constraint was violated in 10.6% and 43.6% of the fractions in Rough OAR and Full OAR methods, respectively (p = 0.075). Patients with a large tumor, a short distance from gross tumor volume (GTV) to OAR, and a tumor in the body or tail were associated with more occult dose constraint violations-large tumor (p = 0.027), short distance from GTV to OAR (p = 0.061), tumor in body or tail (p = 0.054). No dose constraint violation occurred outside 2 cm from the PTV.

Conclusion: More occult dose constraint violations can be found by the Full OAR method in patients with pancreatic cancer with some clinical factors in the online re-planning for SMART. Re-contouring all the OARs would be helpful to detect occult dose constraint violations in SMART planning. Since the dosimetric profile of SMART cannot be represented by a single fraction, patient selection for the Full OAR method should be weighted between the clinical usefulness and the time and workforce required.

Abstract Image

Abstract Image

Abstract Image

磁共振成像引导下胰腺癌适应性放射治疗的剂量学评价:危险器官再轮廓的程度。
目的:在线轮廓和计划用于适应性放疗的安全性尚不清楚。本研究旨在根据立体定向磁共振图像引导的自适应RT (SMART)治疗胰腺癌的轮廓程度来评估危险器官(OAR)的剂量学差异。材料和方法:我们回顾了SMART治疗胰腺癌患者的治疗方案数据。对于在线轮廓和规划,每天根据主治医生的决定重新控制距计划目标体积(PTV) 2厘米内的桨。回顾性地重新绘制整个桨叶的轮廓以进行数据分析。我们将这两种轮廓方法分别称为粗桨形和全桨形。对违反剂量限制的比例及其他剂量学参数进行了分析。结果:19例患者94份SMART纳入分析。粗桨法和全桨法分别有10.6%和43.6%的组分不符合剂量限制(p = 0.075)。肿瘤大、肿瘤总体积(GTV)到OAR距离短、肿瘤在身体或尾部的患者与更多的隐性剂量限制违规相关——肿瘤大(p = 0.027)、肿瘤总体积到OAR距离短(p = 0.061)、肿瘤在身体或尾部(p = 0.054)。距PTV 2cm外未发生违反剂量限制的情况。结论:在对SMART进行在线再规划时,具有一定临床因素的胰腺癌患者采用Full OAR方法可发现更多的隐性剂量约束违规。重新绘制所有桨的轮廓有助于在SMART规划中发现潜在剂量约束违规。由于SMART的剂量学特征不能用一个分数来表示,因此应该在临床有用性和所需的时间和人力之间权衡全桨方法的患者选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
4.30%
发文量
24
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信